Brooks Laboratories Ltd.
NSE: BROOKS | BSE: 533543
₹59.35
₹-2.18
(-3.54%)
As on 21-Sep-2026 12:54IST
Market cap
₹177 Cr
Revenue (TTM)
₹83 Cr
P/E Ratio
13.4
P/B Ratio
1.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹13 Cr
-
ROE
22.3 %
-
ROCE
21.7 %
-
Industry P/E
34.4
-
EV/EBITDA
25.5
-
Debt to Equity
0.1
-
Book Value
₹42.1
-
EPS
₹4.5
-
Face value
10
-
Shares outstanding
29,457,248
10 Years Aggregate
CFO
₹-56.40 Cr
EBITDA
₹-44.86 Cr
Net Profit
₹-126.04 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Brooks Lab
| -25.9 | -1.6 | -11.0 | -60.3 | -15.8 | -15.1 | -4.9 |
|
BSE Healthcare
| 19.8 | 2.6 | 8.7 | 15.0 | 22.4 | 14.8 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Brooks Lab
| -56.4 | 23.4 | 32.6 | 8.9 | 43.9 | 170.4 | -51.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Brooks Lab
|
59.4 | 176.7 | 83.2 | 4.6 | 5.0 | 11.1 | 13.4 | 1.4 |
| 6,714.5 | 16,771.4 | 2,432.1 | 169.6 | 8.7 | 20.8 | 98.9 | 18.5 | |
| 2,768.5 | 21,107.3 | 2,287.3 | 678.1 | 31.4 | 19.7 | 31.7 | 5.7 | |
| 2,223.2 | 13,564.7 | 1,479.1 | 198.6 | 18.6 | 30.3 | 68.2 | 16.8 | |
| 1,296.5 | 18,078.9 | 3,229.7 | 666.9 | 26.6 | 18.8 | 28.1 | 4.5 | |
| 4,030.0 | 18,431.5 | 2,569.8 | 735.2 | 34.4 | 19.2 | 25.1 | 4.2 | |
| 5,521.5 | 9,171.0 | 1,432.9 | 356.9 | 30.8 | 58.2 | 25.7 | 14.9 | |
| 1,059.2 | 20,252.5 | 1,682.5 | 273.5 | 21.0 | 11.1 | 68.1 | 7.5 | |
| 1,252.1 | 11,475.5 | 5,004.4 | 635.3 | 14.5 | 19.8 | 18.7 | 3.5 | |
| 927.2 | 7,387.9 | 872.6 | 198.4 | 29.7 | 17.4 | 37.2 | 6.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Brooks Lab
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials,... lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections. It is also involved in loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries; and trading in pharmaceutical products, ingredients, and intermediaries. In addition, the company offers oncology products and hormonal injections; and formulations for therapeutic areas comprising antibiotic, pain management, controlled drugs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan, Nigeria, Lebanon, Mauritius, Sudan, Madagascar, the Democratic Republic of Congo, Angola, Mozambique, Latin America, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India. Read more
-
Incorporated
2002
-
Chairman
--
-
Managing Director
--
-
Headquarters
Solan Dist, Himachal Pradesh
-
Website
Looking for more details about Brooks Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Brooks Lab
What is the current share price of Brooks Laboratories Ltd Today?
The share price of Brooks Laboratories Ltd is ₹59.35 (NSE) and ₹60.16 (BSE) as of 21-Sep-2026 12:54 IST. Brooks Laboratories Ltd has given a return of -15.79% in the last 3 years.
What is the current PB & PE ratio of Brooks Laboratories Ltd?
The P/E ratio of Brooks Laboratories Ltd is 13.38 times as on 21-Sep-2026, a 61 discount to its peers’ median range of 34.40 times.
The P/B ratio of Brooks Laboratories Ltd is 1.42 times as on 21-Sep-2026, a 72 discount to its peers’ median range of 5.09 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
4.49 |
0.90 |
2025 |
0.00 |
3.24 |
2024 |
0.00 |
3.71 |
2023 |
0.00 |
2.09 |
2022 |
0.00 |
2.05 |
What is the 52 Week High and Low of Brooks Laboratories Ltd?
The 52-week high and low of Brooks Laboratories Ltd are Rs 153.99 and Rs 36.30 as of 21-Sep-2026.
What is the market cap of Brooks Laboratories Ltd?
Brooks Laboratories Ltd has a market capitalisation of ₹ 177 Cr as on 21-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Brooks Laboratories Ltd?
Before investing in Brooks Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.